Citigroup
YDES

Citigroup’s YD Bio Ltd YDES Stock Holding History

Citigroup’s Portfolio YDES Stock Details YDES Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,709
Closed -$20.8K – 6540
2025
Q4 		$20.8K Buy
+1,709
New +$23.1K ﹤0.01% 4858

Other funds holding YDES

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Cerity Partners
Cerity Partners New York $70.8B AUM 21.68% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Citigroup's YDES Position: Q1 2026 in Review

Citigroup sold out of YD Bio Ltd (YDES) in Q1 2026, closing a stake of 1,709 shares — an estimated $20.8K sold.

Citigroup first reported a position in YDES in Q4 2025 and held it in 1 quarter. The position peaked at $20.8K in Q4 2025. 8 funds tracked by Wall St. Rank hold YDES as of Q1 2026.

  • Citigroup reported no remaining YD Bio Ltd position as of Q1 2026 after selling out during the quarter.
  • Citigroup sold 1,709 YD Bio Ltd shares in Q1 2026, an estimated $20.8K.
  • Citigroup first reported a position in YD Bio Ltd in Q4 2025 and held it in 1 quarter.
  • Citigroup's YD Bio Ltd position peaked at $20.8K in Q4 2025.
  • 8 funds tracked by Wall St. Rank held YD Bio Ltd as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.